COURNOYER CHRISTINE 4
4 · CareDx, Inc. · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
CareDx (CDNA) Director Christine Cournoyer Receives RSU Award
What Happened
- Christine Cournoyer, a director of CareDx, Inc. (CDNA), received an award of 9,795 restricted stock units (RSUs) on June 12, 2026. The RSUs were reported as acquired at $0.00 per share (no cash exchanged) and are reported under transaction code "A" (award/grant). This is a grant of equity compensation rather than a market purchase or sale.
Key Details
- Transaction date: 2026-06-12; Filing date (Form 4): 2026-06-16 (timely filed within the 2-business-day requirement).
- Shares/units granted: 9,795 RSUs; reported acquisition price: $0.00.
- Shares owned after transaction: Not specified in the excerpt of the filing provided.
- Footnote: The RSUs vest 100% on the earlier of (a) the one-year anniversary of the grant or (b) the day immediately before the first Annual Meeting after the grant date, subject to Cournoyer’s continuous service on each vesting date.
- Transaction type: Award (A) — not a purchase or sale; no immediate cash proceeds or market activity.
Context
- RSU grants are a common form of director compensation. They do not represent immediate stock ownership until vested; no shares were sold or purchased in the open market in this filing. The vesting condition ties the award to continued service (common for director awards), so these units will convert to shares only if vesting conditions are met.
Insider Transaction Report
Form 4
CareDx, Inc.CDNA
COURNOYER CHRISTINE
Director
Transactions
- Award
Common Stock
[F1]2026-06-12+9,795→ 58,943 total
Footnotes (1)
- [F1]The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.
Signature
/s/ Jeffrey Adam Novack, Attorney-in-Fact|2026-06-16